查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
倍他米松乙酸酯市場：按配方、給藥途徑、應用、年齡組、分銷渠道、地區-規模、份額、前景和機會分析，2022-2030 年
市場調查報告書
商品編碼
1213854

倍他米松乙酸酯市場：按配方、給藥途徑、應用、年齡組、分銷渠道、地區-規模、份額、前景和機會分析，2022-2030 年

Betamethasone Acetate Market, by Formulation, by Route of Administration, by Application, by Age Group, by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 203 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

倍他米松乙酸酯是一種醋酸酯，類固醇酯，17alpha-hydroxy steroid, a 20-oxo steroid, a fluorinated steroid, an 11beta-hydroxy steroid, a 3-oxo-Delta (1), Delta (4)-steroid and a tertiary alpha-hydroxyl ketone。 功能上與倍他米松相關。

Betamethasone acetate 是一種長效皮質類固醇，具有抗炎和免疫抑制特性。 它可以通過腸胃外給藥來治療許多疾病，包括自身免疫性疾病，也可以局部用於治療炎症性皮膚病，包括濕疹。 Betamethasone Sodium Phosphate 和 Betamethasone Acetate Injectable Suspension 也可用於骨骼肌肉或肌腱（神經節）的囊性腫瘤。 Betamethasone Injectable Suspension 用於治療由各種情況引起的炎症和疼痛。 這些病症包括多發性硬化症、關節炎等。

市場動態

由於醋酸倍他米松用於治療腎臟疾病等多種疾病，預計腎臟疾病患病率的增加將推動預測期內的市場增長。 例如，2022 年 7 月，美國疾病控制與預防中心 (CDC) 提供的數據估計，到 2020 年美國將有超過 15% 的成年人，即 3700 萬人患有慢性腎病 (CKD)。是 同樣的數據還發現，CKD 在 65 歲及以上人群 (38%) 中比在 45-64 歲人群 (12%) 和 18-44 歲人群 (6%) 中更常見。

由於 betametha acetate 用於多種醫療條件，例如呼吸系統疾病，預計呼吸系統疾病患病率的增加將在預測期內推動 betametha acetate 的市場增長。 例如，2021 年 8 月，根據世界衛生組織 (WHO) 的數據，到 2020 年將有大約 6500 萬人患有中度至重度慢性阻塞性肺疾病 (COPD)，佔全球所有死亡人數的 5%（每 10 萬人中有 41.9 人死亡）。

這項研究的主要特點

  • 本報告對全球醋酸倍他米松市場進行了深入分析，展示了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%)。
  • 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
  • 它還提供關鍵見解，例如市場促進因素和抑制因素、機會、新產品發佈或批准、市場趨勢、區域前景以及主要參與者採用的競爭戰略。
  • 它根據以下參數介紹了全球醋酸倍他米松市場的主要參與者 - 公司亮點、產品組合、主要亮點、財務業績、戰略 本研究涵蓋的主要參與者包括 Merck & Co., Inc.、 American Regent, Inc., McKesson Medical-Surgical Inc., GNHIndia.com, Lexicon Medical Supply, Medline Industries, Inc., Caspian Tamin Pharmaceutical Co., Sandoz Canada Inc, NorthWestPharmacy.com Inc., Medisca Inc., Exela Pharma Sciences , LLC, Sanofi Pasteur Inc., Sorrento Therapeutics Inc.
  • 這份報告中的見解應該能讓公司的營銷人員和管理人員就未來的產品發佈、類型升級、市場擴張和營銷策略做出明智的決策。.
  • 本研究報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球醋酸倍他米松市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第 2 章市場展望

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場概況：按配方分類
    • 按給藥途徑劃分的市場概況
    • 市場概況：按應用分類
    • 市場概況：按年齡組
    • 市場概況：按分銷渠道
    • 市場概況：按地區
  • 連貫機會圖 (COM)

第 3 章市場動態、規律及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場吸引力分析
    • 市場機會
  • 產品發佈
  • 合併、收購、聯合研究
  • 監管準則和合規性
  • 主要發展狀況
  • 害蟲分析
  • 技術
  • 對 PORTER 的分析
  • 定價分析 (2021)

第 4 章醋酸倍他米鬆的全球市場-冠狀病毒 (COVID-19) 大流行的影響

  • 經濟影響
  • COVID-19 的流行病學特徵
  • 對供需的影響

第 5 章醋酸倍他米鬆的全球市場，按配方，2017-2030

  • 掛液
  • 藥膏
  • 凝膠

第 6 章醋酸倍他米鬆的全球市場：按給藥途徑，2017-2030

  • 肌肉注射
  • 關節內
  • 皮內

第 7 章全球醋酸倍他米松市場應用，2017-2030（百萬美元)

  • 呼吸系統疾病
  • 腎臟疾病
  • 消化系統疾病
  • 眼科疾病
  • 皮膚科領域
  • 其他

第 8 章全球醋酸倍他米松市場：按年齡組分類，2017-2030（百萬美元)

  • 兒科
  • 年老

第 9 章全球醋酸倍他米松市場：按分銷渠道，2017-2030 年（百萬美元）

  • 醫院藥房
  • 零售藥房
  • 在線藥店

第 10 章全球各地區醋酸倍他米松市場，2017-2030

  • 北美
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地區
  • 歐洲
  • 英國
  • 德國
  • 意大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東盟
  • 澳大利亞
  • 韓國
  • 其他亞太地區
  • 中東
  • 海灣合作委員會
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中非
  • 南非

第 11 章競爭格局

  • Merck & Co., Inc.
  • American Regent, Inc.
  • McKesson Medical-Surgical Inc.
  • GNHIndia.com
  • Lexicon Medical Supply
  • Medline Industries, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Sandoz Canada Inc.
  • NorthWestPharmacy.com Inc.
  • Medisca Inc.
  • Exela Pharma Sciences, LLC
  • Sanofi Pasteur Inc.
  • Sorrento Therapeutics Inc.

第 12 章章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5481

Betamethasone acetate is an acetate ester, a steroid ester, a 17alpha-hydroxy steroid, a 20-oxo steroid, a fluorinated steroid, an 11beta-hydroxy steroid, a 3-oxo-Delta (1), Delta (4)-steroid and a tertiary alpha-hydroxyl ketone. It is functionally related to a betamethasone.

Betamethasone acetate is long-acting corticosteroid has anti-inflammatory and immunosuppressive effects. It can be administered parenterally to treat a number of disease states, including autoimmune illnesses, and topically to treat inflammatory skin conditions including eczema. Betamethasone sodium phosphate and betamethasone acetate injectable suspension may also be useful in cystic tumors of an aponeurosis or tendon (ganglia). Betamethasone injectable suspension is used to treat inflammation and pain from a variety of conditions. These conditions include multiple sclerosis, arthritis, and others.

Market Dynamics

The betamethasone acetate is used in various disease conditions such as renal disease, thus the increasing prevalence of renal disease is expected to drive the market growth over the forecast period. For instance, in July 2022, according to data provided by Center of Disease Control and Prevention (CDC), in 2020, more than 15% of the U.S. adults or 37 million people, are estimated to have Chronic Kidney Disease (CKD). Moreover, according to same source CKD is more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%).

The betamethasone acetate is used in various disease condition such as respiratory diseases, thus the increasing prevalence of respiratory disease is expected to drive the betamethasone acetate market growth over the forecast period. For instance, in August 2021, according to the World Health Organization (WHO), in 2020 approximately, 65 million people had moderate to severe Chronic Obstructive Pulmonary Diseases (COPD) that accounts for 5% of deaths (41.9 deaths per 100 000 individuals) globally.

Key features of the study:

  • This report provides in-depth analysis of the global betamethasone acetate market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global betamethasone acetate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck & Co., Inc., American Regent, Inc., McKesson Medical-Surgical Inc., GNHIndia.com, Lexicon Medical Supply, Medline Industries, Inc., Caspian Tamin Pharmaceutical Co., Sandoz Canada Inc, NorthWestPharmacy.com Inc., Medisca Inc, Exela Pharma Sciences, LLC, Sanofi Pasteur Inc., Sorrento Therapeutics Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global betamethasone acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global betamethasone acetate market

Detailed Segmentation:

  • Global Betamethasone Acetate Market, By Formulation:
    • Suspension
    • Ointment
    • Gel
  • Global Betamethasone Acetate Market, By Route of Administration:
    • Intramuscular
    • Intra-articular
    • Intradermal
  • Global Betamethasone Acetate Market By Application:
    • Respiratory Disease
    • Renal Disease
    • Gastrointestinal Disease
    • Ophthalmic Disease
    • Dermatological Disease
    • Others
  • Global Betamethasone Acetate Market By Age Group:
    • Pediatric
    • Geriatric
  • Global Betamethasone Acetate Market By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Betamethasone Acetate Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Merck & Co., Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • American Regent, Inc.
    • McKesson Medical-Surgical Inc.
    • GNHIndia .com
    • Lexicon Medical Supply
    • Medline Industries, Inc.
    • Caspian Tamin Pharmaceutical Co.
    • Sandoz Canada Inc
    • NorthWestPharmacy.com Inc.
    • MEDISCA PHARMACEUTIQUE INC
    • Exela Pharma Sciences, LLC
    • Sanofi Pasteur Inc.
    • Sorrento Therapeutics Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Formulation
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By Age Group
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • PORTER's Analysis
  • Pricing Analysis (2021)

4. Global Betamethasone Acetate Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Betamethasone Acetate Market, By Formulation, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Ointment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Gel
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Betamethasone Acetate Market, By Route of Administration, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Intra-articular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Intradermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Betamethasone Acetate Market, By Application, 2017 - 2030, (US$ Million

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Respiratory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Renal Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Gastrointestinal Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Ophthalmic Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Dermatological Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Betamethasone Acetate Market, By Age Group, 2017 - 2030, (US$ Million

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Betamethasone Acetate Market, By Distribution Channel, 2017 - 2030, (US$ Million

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

10. Global Betamethasone Acetate Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Merck & Co., Inc.*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • American Regent, Inc.
  • McKesson Medical-Surgical Inc.
  • GNHIndia.com
  • Lexicon Medical Supply
  • Medline Industries, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Sandoz Canada Inc.
  • NorthWestPharmacy.com Inc.
  • Medisca Inc.
  • Exela Pharma Sciences, LLC
  • Sanofi Pasteur Inc.
  • Sorrento Therapeutics Inc.

12. Section

  • Research Methodology
  • About Us